期刊文献+

化疗联合靶向药物治疗晚期非小细胞肺癌的疗效及对患者生活质量和免疫功能的影响 被引量:2

原文传递
导出
摘要 肺癌是最常见的恶性肿瘤之一,在全球范围内发病率不断上升,死亡率居恶性肿瘤首位^([1])。WHO将肺癌划分为非小细胞癌(NSCLC)与小细胞癌(SCLC),前者较常见,包括鳞癌、腺癌及大细胞癌,约占总肺癌人数的80%,很多患者发现时已处于中晚期阶段,错失最佳手术时机。临床上治疗NSCLC主要以化疗为主,但化疗是全身性治疗方法,对正常细胞造成损伤,影响患者治疗效果及预后。
出处 《黑龙江中医药》 2021年第5期174-175,共2页 Heilongjiang Journal of Traditional Chinese Medicine
基金 项目编号2014-J-2051-R05/07 新乡市科学技术进步奖贰等奖
  • 相关文献

二级参考文献98

  • 1李孝君,肖锋,肖茂良.参一胶囊联合安罗替尼治疗晚期非小细胞肺癌的临床研究[J].湖南师范大学学报(医学版),2020,17(1):81-84. 被引量:12
  • 2Molina JR,Yang P,Cassivi SD,et al.Non-small cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J] .Mayo Clin Proc,2008,83(5):584-594.
  • 3Riely GJ,Politi KA,Miller VA,et al.Update on epidermal growth factor receptor mutations in non-small cell lung cancer[J] .Clin Cancer Res,2006,12(24):7232-7241.
  • 4Sequist LV,Martins RG,Spigel D,et al.First-line gefitinib in patients with advanced non-small-cell lung cancer harboring somatic EGFR mutations[J] .J Clin Oncol,2008,26(15):2442-2449.
  • 5Onitsuka T,Uramoto H,Nose N,et al.Acquire resistance to gefitinib:the contribution of mechanisms other than the T790M,MET,and HGF status[J] .Lung Cancer,2010,68(2):198-203.
  • 6Su KY,Chen HY,Li KC,et al.Pretreatment epidermal growth factor receptor (EGFR) T790M mutation predicts shorter EGFR tyrosine kinase inhibitor response duration in patients with nonsmall-cell lung cancer[J] .J Clin Oncol,2012,30(4):433-440.
  • 7Shi Y,Au JS,Thoagprasert S,et al.A prospective,molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER)[J] .J Thorac Oncol,2014,9(2):154-162.
  • 8Soda M,Choi YL,Enomoto M,et al.Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer[J] .Nature,2007,448(7153):561-566.
  • 9Inamura K,Takeuchi K,Togashi Y,et al.EML4-ALK lung cancers are characterized by rare other mutations,a TTF-1 cell lineage,an acinar histology,and young onset[J] .Mod Pathol,2009,22 (4):508-515.
  • 10Shaw AT,Yeap BY,Mino-Kenudson M,et al.Clinical features and outcome of patients with non-small-cell lung cancer who harbor EML4-ALK[J] .J Clin Oncol,2009,27(26):4247-4253.

共引文献119

同被引文献24

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部